Developing countries are seeking to pay as little as 1 percent of the $84,000 price Gilead Sciences Inc. is charging U.S. patients for its new hepatitis C drug. Wealthier countries such as Ukraine and China may not be so lucky, according to Doctors Without Borders, the nonprofit international aid group.
An outbreak of Ebola that has killed at least 85 people in West Africa is drawing aid from U.S. disease fighters who will help track the deadly path of a virus with no cure that is fatal in about 90 percent of cases.
U.K. biotechnology start-up Oxitec Ltd. wants to start U.S. tests of a new weapon in the war on dengue fever: genetically modifying mosquitoes that carry the disease so that their progeny self-destruct.
GlaxoSmithKline Plc’s experimental malaria vaccine safely reduced illness in African infants by more than half, a finding that’s a step toward its eventual use in preventing the deaths of as many as 800,000 children a year.
After retired race car star Michael Schumacher severely injured his head in a fall while skiing last month, doctors in France removed part of his skull to relieve dangerous swelling in his brain. How much their treatment will help in the long run is an open question.
The financial catastrophe in Greece is damaging public health and wellbeing, according to six medical academics including Alexander Kentikelenis and David Stuckler of Cambridge University and Martin McKee of the London School of Hygiene and Tropical Medicine.